Back to search

United Kingdom· GB-APID-23444411000001105

Reprapog 250mg/100mg tablets

A proguanil and atovaquone product containing proguanil + atovaquone, registered in United Kingdom by Sandoz Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC P01BB51

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedReprapog 250mg/100mg tabletsATCP01BB51REGISTER NO.GB-APID-2344441100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Proguanil and atovaquone is registered in 13 of 19 countries.

Countries holding a registration under ATC P01BB51 (proguanil and atovaquone), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Proguanil and atovaquone · ATC P01BB51

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of proguanil and atovaquone costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Proguanil and atovaquone · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$5.96
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Proguanil + Atovaquone
Manufacturer
Sandoz Ltd
Country
United Kingdom (GB)
ATC code
P01BB51
ATC class
Proguanil and atovaquone
Defined daily dose
0.4 g, Proguanilhydroch
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5050650115024

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for proguanil and atovaquone.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Proguanil and atovaquone · interactions on record

40 records

  • 4 severe
  • 27 moderate
  • 3 minor

Most severe, free to view

  • EfavirenzJ05AG03severe
  • Sodium aurothiomalateM01CB01severe
  • AuranofinM01CB03severe
  • AurothioglucoseM01CB04severe

6 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Proguanil and atovaquone in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All proguanil and atovaquone products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Atovaquon/Proguanilhydrochlorid Glenmark, Atovaquon/Proguanilhydrochlorid Stada
  • Belgium · Atovaquone/Proguanil Eg, Atovaquone/Proguanil Viatris
  • Czechia · Malarone
  • Germany · Atovaquon/Proguanilhydrochlorid Al, Atovaquon/Proguanilhydrochlorid Amarox
  • Denmark · Atovaquon/Proguanilhydrochlorid Glenmark, Malarone
  • Estonia · Malarone, Malarone Paediatric
  • Spain · Atovacuona/Hidrocloruro De Proguanil Viatris, Malarone
  • Finland · Malarone
  • France · Atovaquone/Proguanil Bgr, Atovaquone/Proguanil Biogaran
  • Greece · Malarone
  • Hungary · Malarone
  • Ireland · Atovaquone/Proguanil Hydrochloride Glenmark Arzneimittel, Atovaquone/Proguanil Hydrochloride Viatris
  • Iceland · Malarone, Malastad
  • Italy · Atovaquone E Proguanile Mylan Generics, Malarone
  • Lithuania · Malarone
  • Luxembourg · Atovaquon/Proguanilhydrochlorid Ratiopharm, Atovaquone/Proguanil Eg
  • Latvia · Malarone
  • Malta · Atovaquone/Proguanil Hydrochloride Amarox, Malarone
  • Netherlands · Atovaquon/Proguanil Hcl Amarox, Atovaquon/Proguanil Hcl Cf
  • Norway · Atovakon/Proguanil Glenmark, Malarone
  • Poland · Falcimar, Malarone
  • Portugal · Malarone
  • Sweden · Atovaquone / Proguanil Glenmark, Malarone Junior
  • Slovenia · Malarone
  • Slovakia · Malarone

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f152eaaf-fadc-49d6-877e-3530b8765926
GET /v1/drugs/f152eaaf-fadc-49d6-877e-3530b8765926?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "23444411000001105",
  "desc": "Reprapog 250mg/100mg tablets (Sandoz Ltd)",
  "form": "Oral tablet",
  "vpid": "39733311000001109",
  "source": "dmd",
  "vtm_id": "774693003",
  "strength": "100 mg",
  "substance": "Proguanil + Atovaquone",
  "ingredient": "Proguanil hydrochloride",
  "supplier_code": "2074301000001102"
}

See everything about proguanil and atovaquone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.